Histopathological effects and recovery rate of rat bladders following intravesical instillation of thiotepa, doxorubicin and mitomycin C.

A study was made of the local reactions and systemic effects induced by intravesical instillations of thiotepa, doxorubicin and mitomycin C in rats. The control group received normal saline. In the 1-dose short-term experiments, rats treated with doxorubicin and mitomycin C had a high incidence of chemical reactions, including congestion of the mucosa with methylene blue stain, increased bladder weight with oedematous changes either in the mucosa (doxorubian) or the muscle layer (mitomycin C), and infiltration of polymorphonuclear cells 3 days after instillation. These local changes disappeared within 10 days. In long-term experiments with weekly instillations of chemotherapeutic drugs, the rats showed no significant change in weight, methylene blue staining or mucosal congestion. A high percentage of pyuria and microscopic haematuria with submucosal/muscular fibrosis was noted in rats receiving doxorubicin or mitomycin C. A severe dysplastic change in the urothelium was noted in rats treated with mitomycin C. These results suggest that careful follow-up is required in patients receiving intravesical doxorubicin or mitomycin C because of possible severe side effects in the bladder.

[1]  U. Mooppan,et al.  The effect of intravesical instillations of thiotepa, mitomycin C, and adriamycin on normal urothelium: an experimental study in rats. , 1991, The Journal of urology.

[2]  M. Lamartina,et al.  Intravesical instillation of adriamycin in treatment of bladder cancer. A review. , 1984, Urology.

[3]  H. Ch Studies of the morphological effects of thiotepa and adriamycin on urothelium. , 1984 .

[4]  D. Bagley,et al.  In vivo urothelial surface histology by microscopic chromocystoscopy. , 1983, Journal of Urology.

[5]  M. Soloway,et al.  The morphologic effects of mitomycin c in mammalian urinary bladder , 1981, Cancer.

[6]  G. Jakse,et al.  Intracavitary doxorubicin hydrochloride therapy for carcinoma in situ of the bladder. , 1981, The Journal of urology.

[7]  M. J. Droller Transitional cell carcinoma: an overview. , 1980, The Urologic clinics of North America.

[8]  M. J. Droller Cancer of the testis: an overview. , 1980, The Urologic clinics of North America.

[9]  B. Peterson,et al.  Cytologic effects of Thiotepa and Adriamycin on normal canine urothelium. , 1980, Acta cytologica.

[10]  J. Pontes,et al.  Topical instillation of doxorubicin hydrochloride in the treatment of recurring superficial transitional cell carcinoma of the bladder. , 1977, The Journal of urology.

[11]  S. Murata,et al.  Mitomycin C bladder instillation therapy for bladder tumors. , 1975, The Journal of urology.

[12]  L. Ose Letter: L.D.L. and total cholesterol in cord-blood screening for familial hypercholesterolaemia. , 1975, Lancet.

[13]  C. Cox,et al.  Bladder cancer: a 26-year review. , 1969, The Journal of urology.

[14]  A. Dean,et al.  Bladder carcinoma treated by direct instillation of thio-TEPA. , 1962, The Journal of urology.

[15]  H. C. Jones,et al.  Thiotepa in the treatment of tumours of the bladder. , 1961, Lancet.